Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup

• US 7,510,827 B2
• Filed: 03/31/2004
• Issued: 03/31/2009
• Est. Priority Date: 03/31/2003
• Status: Active Grant

• Current Assignee: Roche Molecular Systems (Roche Holding AG)
• Original Assignee: Roche Molecular Systems (Roche Holding AG)
• Inventors: Young, Karen K. Y.
• Primary Examiner(s): MOSHER, MARY
• Application Number:
  US10/815,480
• Publication Number:
  US 20040229261A1
• Time in Patent Office: 1,826 Days
• Field of Search: 435/6, 435/194, 435/91.2, 435/286.1
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/701 Specific hybridization probes
• CPC Class Codes: C12Q 2600/158 Expression markers
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3′ untranslated region of the viral genomes to be detected.

Claims

1. A kit for the detection of a nucleic acid of a member of the Japanese encephalitis virus serogroup, comprising:

a) a first oligonucleotide that comprises SEQ ID NO.;

4;

b) a second oligonucleotide that comprises SEQ ID NO;

12; and

c) a detectably-labeled third oligonucleotide that comprises SEQ ID NO;

20,

wherein the first and second oligonucleotide lengths are from 25 to 100 nucleotides, and the third oligonucleotide length is from 28 to 100 nucleotides.

2. The kit of claim 1, wherein the first oligonucleotide comprises SEQ ID NO:

8.

3. The kit of claim 1, wherein the third oligonucleotide comprises SEQ ID NO:

28.

4. The kit of claim 1, wherein:

the first oligonucleotide comprises SEQ ID NO;

8;

the second oligonucleotide comprises SEQ ID NO;

12; and

the third oligonucleotide comprises SEQ ID NO;

28.

5. The kit of claim 1, wherein:

the first oligonucleotide comprises SEQ ID NO;

8;

the second oligonucleotide comprises SEQ ID NO;

74; and

the third oligonucleotide comprises SEQ ID NO;

28.

6. The kit of claim 2, wherein the residue at position 24 of SEQ ID NO.:

8 is N6-alkyl-deoxyadenosine.

7. The kit of claim 6, wherein the residue at position 24 of SEQ ID NO.:

8 is N6-methyl-deoxyadenosine.

8. The kit of claim 2, wherein the residue at position 25 of SEQ ID NO.:

8 is N6-alkyl-deoxyadenosine.

9. The kit of claim 8, wherein the residue at position 25 of SEQ ID NO.:

8 is N6-tert-butylbenzyl-deoxyadenosine.

10. The kit of claim 2, wherein the residue at position 24 of SEQ ID NO.:

8 is N6-methyldeoxyadenosine and the residue at position 25 of SEQ ID NO.;

8 is N6-tert-butyl-benzyldeoxyadenosine.

11. The kit of claim 1, wherein the second oligonucleotide comprises SEQ ID NO.:

15.

12. The kit of claim 11, wherein the residue at position 23 of SEQ ID NO.:

15 is N6-alkyl-deoxyadenosine.

13. The kit of claim 11, wherein the residue at position 23 of SEQ ID NO.:

15 is N6-alkyldeoxyadenosine.

14. The kit of claim 11, wherein the second oligonucleotide comprises SEQ ID NO.:

74.

15. The kit of claim 14, wherein the residue at position 25 of SEQ ID NO.:

74 is N6-alkyldeoxyadenosine.

16. The kit of claim 14, wherein the residue at position 25 of SEQ ID NO.:

74 is N6-tertbutyl-benzyl-deoxyadenosine.

17. The kit of claim 1, wherein the detectably-labeled third oligonucleotide comprises SEQ ID NO.:

28.

18. The kit of claim 17, wherein the detectablylabeled third oligonucleotide comprises a fluorescent moiety.

19. The kit of claim 18, wherein the detectably-labeled third oligonucleotide further comprises a quencher moiety.

20. The kit of claim 18, wherein the fluorescent moiety is selected from the group consisting of fluorescein-family dyes, polyhalofluorescein-family dyes, hexachlorofluorescein-family dyes, coumarin-family dyes, rhodamine-family dyes, cyanine-family dyes, oxazine-family dyes, thiazine-family dyes, squaraine family dyes, chelated lanthanide-family dyes, and BODIPY®

-family dyes.

21. The kit of claim 18, wherein the fluorescent moiety is 6-carboxyfluorescein.

22. The kit of claim 19, wherein the quencher moiety is selected from the group consisting of fluorescein-family dyes, polyhalofluorescein-family dyes, hexachlorofluorescein-family dyes, coumarin-family dyes, rhodamine-family dyes, cyanine-family dyes, oxazine-family dyes, thiazine-family dyes, squaraine family dyes, chelated lanthanide-family dyes, BODIPY®

-family dyes, and nonfluorescent quencher moieties.

23. The kit of claim 22, wherein the non-fluorescent quencher moiety is BHQ™

-family dyes, Iowa Black™

, or Dabcyl.

24. The kit of claim 19, wherein the quencher moiety is Cy5™

.

25. The kit of claim 1, additionally comprising a thermostable DNA polymerase.

26. The kit of claim 25, wherein the thermostable DNA polymerase is selected from the group of Carboxydothermus hydrogenformans DNA polymerase, Thermosipho africanus DNA polymerase, Bacillus pallidus DNA polymerase, Thermus species Z05 DNA polymerase, Thermus aquatidus DNA polymerase, Thermus thermophilus DNA polymerase, Thermatoga maritima DNA polymerase, Thermatoga neapolitana DNA polymerase, and Thermus sps 17 DNA polymerase.

27. The kit of claim 1, additionally comprising instructions for detecting a nucleic acid of a member of the Japanese encephalitis virus serogroup.